Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Vps52 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Vps52 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of VPS52 mRNA | CTD | PMID:22206623 | Vps52 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | VPS52 (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of VPS52 protein | CTD | PMID:31675489 | Vps52 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VPS52 mRNA | CTD | PMID:34747641 | Vps52 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of VPS52 mRNA | CTD | PMID:21346803 | Vps52 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of VPS52 mRNA | CTD | PMID:21346803 | Vps52 | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of VPS52 protein | CTD | PMID:31675489 | Vps52 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Vps52 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of VPS52 mRNA | CTD | PMID:20188158 | Vps52 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | VPS52 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Vps52 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Vps52 (Mus musculus) | 6480464 | bisphenol S affects the methylation of VPS52 gene | CTD | PMID:31683443 | Vps52 | Rat | 5-fluorouracil | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Fluorouracil results in decreased expression of VPS52 mRNA | CTD | PMID:16709241 | Vps52 | Rat | acrylamide | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of VPS52 mRNA | CTD | PMID:32763439 | Vps52 | Rat | Aflatoxin B2 alpha | decreases methylation | ISO | VPS52 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of VPS52 exon | CTD | PMID:30157460 | Vps52 | Rat | all-trans-retinoic acid | increases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of VPS52 mRNA | CTD | PMID:33167477 | Vps52 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of VPS52 mRNA | CTD | PMID:16483693 | Vps52 | Rat | arsane | affects methylation | ISO | VPS52 (Homo sapiens) | 6480464 | Arsenic affects the methylation of VPS52 gene | CTD | PMID:25304211 | Vps52 | Rat | arsenic atom | affects methylation | ISO | VPS52 (Homo sapiens) | 6480464 | Arsenic affects the methylation of VPS52 gene | CTD | PMID:25304211 | Vps52 | Rat | benzo[a]pyrene | affects methylation | ISO | VPS52 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of VPS52 intron | CTD | PMID:30157460 | Vps52 | Rat | benzo[a]pyrene | decreases methylation | ISO | VPS52 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of VPS52 3' UTR | CTD | PMID:27901495 | Vps52 | Rat | benzo[e]pyrene | decreases methylation | ISO | VPS52 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of VPS52 intron | CTD | PMID:30157460 | Vps52 | Rat | bisphenol A | increases expression | ISO | Vps52 (Mus musculus) | 6480464 | bisphenol A results in increased expression of VPS52 mRNA | CTD | PMID:18804091 | Vps52 | Rat | bisphenol A | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of VPS52 mRNA; bisphenol A results in decreased expression more ... | CTD | PMID:31675489|PMID:33670352 | Vps52 | Rat | bisphenol A | multiple interactions | ISO | Vps52 (Mus musculus) | 6480464 | [NR1H4 gene mutant form affects the susceptibility to bisphenol A] which results in decreased expression more ... | CTD | PMID:30245210 | Vps52 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of VPS52 mRNA | CTD | PMID:25181051 | Vps52 | Rat | bisphenol F | multiple interactions | ISO | VPS52 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Vps52 | Rat | butanal | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of VPS52 mRNA | CTD | PMID:26079696 | Vps52 | Rat | cadmium atom | multiple interactions | ISO | Vps52 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VPS52 more ... | CTD | PMID:37236586 | Vps52 | Rat | cadmium dichloride | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of VPS52 mRNA | CTD | PMID:38174414 | Vps52 | Rat | cadmium dichloride | multiple interactions | ISO | Vps52 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VPS52 more ... | CTD | PMID:37236586 | Vps52 | Rat | cisplatin | affects response to substance | ISO | VPS52 (Homo sapiens) | 6480464 | VPS52 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | Vps52 | Rat | copper(II) sulfate | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of VPS52 mRNA | CTD | PMID:19549813 | Vps52 | Rat | cyclosporin A | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of VPS52 mRNA | CTD | PMID:20106945 | Vps52 | Rat | D-gluconic acid | increases expression | EXP | | 6480464 | gluconic acid results in increased expression of VPS52 mRNA | CTD | PMID:16556975 | Vps52 | Rat | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of VPS52 mRNA | CTD | PMID:23640034 | Vps52 | Rat | dexamethasone | multiple interactions | ISO | VPS52 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Vps52 | Rat | Dibutyl phosphate | affects expression | ISO | VPS52 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of VPS52 mRNA | CTD | PMID:37042841 | Vps52 | Rat | dicrotophos | increases expression | ISO | VPS52 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of VPS52 mRNA | CTD | PMID:28302478 | Vps52 | Rat | dorsomorphin | multiple interactions | ISO | VPS52 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Vps52 | Rat | ethanol | affects splicing | ISO | Vps52 (Mus musculus) | 6480464 | Ethanol affects the splicing of VPS52 mRNA | CTD | PMID:30319688 | Vps52 | Rat | genistein | decreases expression | ISO | Vps52 (Mus musculus) | 6480464 | Genistein results in decreased expression of VPS52 mRNA | CTD | PMID:32186404 | Vps52 | Rat | indometacin | multiple interactions | ISO | VPS52 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Vps52 | Rat | ivermectin | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of VPS52 protein | CTD | PMID:32959892 | Vps52 | Rat | methapyrilene | decreases methylation | ISO | VPS52 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of VPS52 intron | CTD | PMID:30157460 | Vps52 | Rat | paracetamol | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of VPS52 mRNA | CTD | PMID:29067470 | Vps52 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of VPS52 mRNA | CTD | PMID:33387578 | Vps52 | Rat | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of VPS52 mRNA | CTD | PMID:19162173 | Vps52 | Rat | SB 431542 | multiple interactions | ISO | VPS52 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Vps52 | Rat | sevoflurane | increases expression | ISO | Vps52 (Mus musculus) | 6480464 | Sevoflurane results in increased expression of VPS52 protein | CTD | PMID:35249202 | Vps52 | Rat | sodium arsenite | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of VPS52 mRNA | CTD | PMID:38568856 | Vps52 | Rat | thiram | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Thiram results in decreased expression of VPS52 mRNA | CTD | PMID:38568856 | Vps52 | Rat | urethane | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Urethane results in decreased expression of VPS52 mRNA | CTD | PMID:28818685 | Vps52 | Rat | valproic acid | affects expression | ISO | Vps52 (Mus musculus) | 6480464 | Valproic Acid affects the expression of VPS52 mRNA | CTD | PMID:17963808 | Vps52 | Rat | valproic acid | affects expression | ISO | VPS52 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of VPS52 mRNA | CTD | PMID:25979313 | Vps52 | Rat | valproic acid | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of VPS52 mRNA | CTD | PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799 | Vps52 | Rat | valproic acid | multiple interactions | ISO | VPS52 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Vps52 | Rat | vorinostat | decreases expression | ISO | VPS52 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of VPS52 mRNA | CTD | PMID:27188386 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















